Senhe Pharmaceutical: plans to repurchase shares of no more than 500 million yuan.

Announcement by Sinopharm Group on August 21, 2025, the board of directors has decided to exercise the repurchase authorization to repurchase shares on the open market for a total amount not exceeding 500 million RMB.